Benazepril hydrochloride and hydrochlorothiazide - Benazepril hydrochloride and hydrochlorothiazide
Navigation: NDC > Supplier starting with: R > RANBAXY PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 63304-155 |
| Proprietary Name: | Benazepril hydrochloride and hydrochlorothiazide |
| Suffix: | |
| Non-Proprietary Name: | Benazepril hydrochloride and hydrochlorothiazide |
| Dosage Form: | TABLET, COATED |
| Method: | ORAL |
| Original Marketing Date: | 10-04-2006 |
| Category Name: | ANDA |
| Application Number: | ANDA077483 |
| Labeler: | RANBAXY PHARMACEUTICALS INC. |
| Substance Name: | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| Active Numerator Strength: | 10; 12.5 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |